POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma - A standard of care?
作者信息
Ranjan Satish Kumar
机构信息
Department of Urology, AIIMS, Rishikesh, Uttarakhand, India.
出版信息
Indian J Urol. 2020 Oct-Dec;36(4):324-326. doi: 10.4103/iju.IJU_217_20. Epub 2020 Oct 1.
Abstract
摘要
相似文献
1
POUT trial: Perioperative chemotherapy in upper tract urothelial carcinoma - A standard of care?POUT试验：上尿路尿路上皮癌的围手术期化疗——一种标准治疗方法？
Indian J Urol. 2020 Oct-Dec;36(4):324-326. doi: 10.4103/iju.IJU_217_20. Epub 2020 Oct 1.
2
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.关于：上尿路尿路上皮癌的辅助化疗（POUT试验）：一项3期、开放标签、随机对照试验。
Eur Urol. 2020 Oct;78(4):630-631. doi: 10.1016/j.eururo.2020.04.021. Epub 2020 May 22.
3
Re: Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (the POUT Trial): A Phase 3, Open-label, Randomised Controlled Trial.关于：上尿路尿路上皮癌的辅助化疗（POUT试验）：一项3期、开放标签、随机对照试验。
Eur Urol. 2020 Aug;78(2):289-290. doi: 10.1016/j.eururo.2020.04.006. Epub 2020 Apr 28.
4
Urothelial carcinoma of the bladder and the upper tract: disparate twins.膀胱和上尿路尿路上皮癌：迥异的双生子。
J Urol. 2013 Apr;189(4):1214-21. doi: 10.1016/j.juro.2012.05.079. Epub 2012 Sep 27.
5
Perioperative chemotherapy for urothelial carcinoma of the upper urinary tract: A systematic review and meta-analysis.上尿路尿路上皮癌的围手术期化疗：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2018 Aug;128:58-64. doi: 10.1016/j.critrevonc.2018.05.005. Epub 2018 May 22.
6
Epidermal growth factor receptor inhibitor with fluorouracil, leucovorin, and irinotecan as an alternative treatment for advanced upper tract urothelial carcinoma: a case report.表皮生长因子受体抑制剂联合氟尿嘧啶、亚叶酸钙和伊立替康作为晚期上尿路尿路上皮癌的替代治疗：一例报告
J Med Case Rep. 2016 Apr 18;10:98. doi: 10.1186/s13256-016-0879-6.
7
Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.组织学亚型对上尿路尿路上皮癌患者临床结局的影响。
J Urol. 2012 Aug;188(2):398-404. doi: 10.1016/j.juro.2012.04.009. Epub 2012 Jun 13.
8
Clinical practice patterns for upper tract urothelial carcinoma: a nationwide survey in Japan.上尿路尿路上皮癌的临床实践模式：日本全国性调查
Jpn J Clin Oncol. 2016 Aug;46(8):768-74. doi: 10.1093/jjco/hyw072. Epub 2016 Jun 6.
9
Perioperative Chemotherapy on Survival in Patients With Upper Urinary Tract Urothelial Carcinoma Undergoing Nephroureterectomy: A Population-Based Study.接受肾输尿管切除术的上尿路尿路上皮癌患者围手术期化疗对生存的影响：一项基于人群的研究
Front Oncol. 2020 Apr 21;10:481. doi: 10.3389/fonc.2020.00481. eCollection 2020.
10
Impact of tumour location versus multifocality in patients with upper tract urothelial carcinoma treated with nephroureterectomy and bladder cuff excision: a homogeneous series without perioperative chemotherapy.在上尿路尿路上皮癌患者接受肾输尿管切除术和膀胱袖状切除术治疗中，肿瘤位置与多灶性的影响：无围手术期化疗的同质系列。
BJU Int. 2012 Jul;110(2 Pt 2):E7-13. doi: 10.1111/j.1464-410X.2011.10792.x. Epub 2011 Dec 16.
引用本文的文献
1
The grimacing face of adverse upper tract urothelial carcinoma can now POUT with adjuvant chemotherapy!上尿路尿路上皮癌的严峻面容现在可以通过辅助化疗展现出“撅嘴”的样子了！ （此译文是在尽量保留原文形象表述基础上的翻译，可能在医学语境下还需结合专业知识进一步理解其确切含义）
Indian J Urol. 2024 Oct-Dec;40(4):281-282. doi: 10.4103/iju.iju_87_24. Epub 2024 Aug 30.
本文引用的文献
1
Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.在上尿路尿路上皮癌中的辅助化疗（POUT 试验）：一项 3 期、开放标签、随机对照试验。
Lancet. 2020 Apr 18;395(10232):1268-1277. doi: 10.1016/S0140-6736(20)30415-3. Epub 2020 Mar 5.
2
High Response Rates to Neoadjuvant Chemotherapy in High-Grade Upper Tract Urothelial Carcinoma.高级别上尿路尿路上皮癌新辅助化疗的高缓解率。
Urology. 2019 Jul;129:146-152. doi: 10.1016/j.urology.2019.01.058. Epub 2019 Mar 28.
3
Effect of neoadjuvant chemotherapy on locally advanced upper tract urothelial carcinoma: A systematic review and meta-analysis.新辅助化疗对局部晚期上尿路上皮癌的疗效：系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2019 Mar;135:59-65. doi: 10.1016/j.critrevonc.2019.01.019. Epub 2019 Jan 31.
4
Cancer statistics, 2019.癌症统计数据，2019 年。
CA Cancer J Clin. 2019 Jan;69(1):7-34. doi: 10.3322/caac.21551. Epub 2019 Jan 8.
5
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-Analysis.肌肉浸润性膀胱癌的新辅助化疗：系统评价和两步荟萃分析
Oncologist. 2016 Jun;21(6):708-15. doi: 10.1634/theoncologist.2015-0440. Epub 2016 Apr 6.
6
Adjuvant chemotherapy for invasive bladder cancer: a 2013 updated systematic review and meta-analysis of randomized trials.浸润性膀胱癌辅助化疗：2013 年更新的随机试验系统评价和荟萃分析。
Eur Urol. 2014 Jul;66(1):42-54. doi: 10.1016/j.eururo.2013.08.033. Epub 2013 Aug 28.
7
Prognostic value of extranodal extension and other lymph node parameters in patients with upper tract urothelial carcinoma.上尿路尿路上皮癌患者的结外侵犯和其他淋巴结参数的预后价值。
J Urol. 2012 Mar;187(3):845-51. doi: 10.1016/j.juro.2011.10.158. Epub 2012 Jan 15.
8
Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer.一项比较吉西他滨联合顺铂与甲氨蝶呤、长春碱、阿霉素联合顺铂治疗膀胱癌患者的随机试验的长期生存结果。
J Clin Oncol. 2005 Jul 20;23(21):4602-8. doi: 10.1200/JCO.2005.07.757.
Zotero 插件